183 related articles for article (PubMed ID: 32351780)
1. Comparative proteogenomics profiling of non-small and small lung carcinoma cell lines using mass spectrometry.
Wu J; Hao Z; Ma C; Li P; Dang L; Sun S
PeerJ; 2020; 8():e8779. PubMed ID: 32351780
[TBL] [Abstract][Full Text] [Related]
2. Current status of clinical proteogenomics in lung cancer.
Nishimura T; Nakamura H; Végvári Á; Marko-Varga G; Furuya N; Saji H
Expert Rev Proteomics; 2019 Sep; 16(9):761-772. PubMed ID: 31402712
[No Abstract] [Full Text] [Related]
3. Data from quantitative proteomic analysis of lung adenocarcinoma and squamous cell carcinoma primary tissues using high resolution mass spectrometry.
Khan AA; Mangalaparthi KK; Advani J; Prasad TSK; Gowda H; Jain D; Chatterjee A
Data Brief; 2018 Aug; 19():1631-1637. PubMed ID: 30229035
[TBL] [Abstract][Full Text] [Related]
4. Proteogenomic interrogation of cancer cell lines: an overview of the field.
Tsang O; Wong JWH
Expert Rev Proteomics; 2021 Mar; 18(3):221-232. PubMed ID: 33877947
[No Abstract] [Full Text] [Related]
5. Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies.
Liu Q; Zhang J; Guo C; Wang M; Wang C; Yan Y; Sun L; Wang D; Zhang L; Yu H; Hou L; Wu C; Zhu Y; Jiang G; Zhu H; Zhou Y; Fang S; Zhang T; Hu L; Li J; Liu Y; Zhang H; Zhang B; Ding L; Robles AI; Rodriguez H; Gao D; Ji H; Zhou H; Zhang P
Cell; 2024 Jan; 187(1):184-203.e28. PubMed ID: 38181741
[TBL] [Abstract][Full Text] [Related]
6. Expression of placental growth factor gene in lung cancer.
Woo IS; Park MJ; Byun JH; Hong YS; Lee KS; Park YS; Lee JA; Park YI; Ahn HK
Tumour Biol; 2004; 25(1-2):1-6. PubMed ID: 15192305
[TBL] [Abstract][Full Text] [Related]
7. Statistical and Computational Methods for Proteogenomic Data Analysis.
Song X
Methods Mol Biol; 2023; 2629():271-303. PubMed ID: 36929082
[TBL] [Abstract][Full Text] [Related]
8. Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune evasion mechanisms.
Lehtiö J; Arslan T; Siavelis I; Pan Y; Socciarelli F; Berkovska O; Umer HM; Mermelekas G; Pirmoradian M; Jönsson M; Brunnström H; Brustugun OT; Purohit KP; Cunningham R; Foroughi Asl H; Isaksson S; Arbajian E; Aine M; Karlsson A; Kotevska M; Gram Hansen C; Drageset Haakensen V; Helland Å; Tamborero D; Johansson HJ; Branca RM; Planck M; Staaf J; Orre LM
Nat Cancer; 2021 Nov; 2(11):1224-1242. PubMed ID: 34870237
[TBL] [Abstract][Full Text] [Related]
9. Integrated Proteomic Pipeline Using Multiple Search Engines for a Proteogenomic Study with a Controlled Protein False Discovery Rate.
Park GW; Hwang H; Kim KH; Lee JY; Lee HK; Park JY; Ji ES; Park SR; Yates JR; Kwon KH; Park YM; Lee HJ; Paik YK; Kim JY; Yoo JS
J Proteome Res; 2016 Nov; 15(11):4082-4090. PubMed ID: 27537616
[TBL] [Abstract][Full Text] [Related]
10. Integration of Proteomics and Transcriptomics Data Sets for the Analysis of a Lymphoma B-Cell Line in the Context of the Chromosome-Centric Human Proteome Project.
Díez P; Droste C; Dégano RM; González-Muñoz M; Ibarrola N; Pérez-Andrés M; Garin-Muga A; Segura V; Marko-Varga G; LaBaer J; Orfao A; Corrales FJ; De Las Rivas J; Fuentes M
J Proteome Res; 2015 Sep; 14(9):3530-40. PubMed ID: 26216070
[TBL] [Abstract][Full Text] [Related]
11. Proteomic profiles of human lung adeno and squamous cell carcinoma using super-SILAC and label-free quantification approaches.
Zhang W; Wei Y; Ignatchenko V; Li L; Sakashita S; Pham NA; Taylor P; Tsao MS; Kislinger T; Moran MF
Proteomics; 2014 Mar; 14(6):795-803. PubMed ID: 24453208
[TBL] [Abstract][Full Text] [Related]
12. Exome-based proteogenomics of HEK-293 human cell line: Coding genomic variants identified at the level of shotgun proteome.
Lobas AA; Karpov DS; Kopylov AT; Solovyeva EM; Ivanov MV; Ilina IY; Lazarev VN; Kuznetsova KG; Ilgisonis EV; Zgoda VG; Gorshkov MV; Moshkovskii SA
Proteomics; 2016 Jul; 16(14):1980-91. PubMed ID: 27233776
[TBL] [Abstract][Full Text] [Related]
13. High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data.
Gomig THB; Cavalli IJ; Souza RLR; Lucena ACR; Batista M; Machado KC; Marchini FK; Marchi FA; Lima RS; Urban CA; Cavalli LR; Ribeiro EMSF
Data Brief; 2019 Aug; 25():104125. PubMed ID: 31294064
[TBL] [Abstract][Full Text] [Related]
14. Differential disruption of cell cycle pathways in small cell and non-small cell lung cancer.
Coe BP; Lockwood WW; Girard L; Chari R; Macaulay C; Lam S; Gazdar AF; Minna JD; Lam WL
Br J Cancer; 2006 Jun; 94(12):1927-35. PubMed ID: 16705311
[TBL] [Abstract][Full Text] [Related]
15. Developing Well-Annotated Species-Specific Protein Databases Using Comparative Proteogenomics.
Dupree EJ; Crimmins BS; Holsen TM; Darie CC
Adv Exp Med Biol; 2019; 1140():389-400. PubMed ID: 31347060
[TBL] [Abstract][Full Text] [Related]
16. Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.
Wang J; Mouradov D; Wang X; Jorissen RN; Chambers MC; Zimmerman LJ; Vasaikar S; Love CG; Li S; Lowes K; Leuchowius KJ; Jousset H; Weinstock J; Yau C; Mariadason J; Shi Z; Ban Y; Chen X; Coffey RJC; Slebos RJC; Burgess AW; Liebler DC; Zhang B; Sieber OM
Gastroenterology; 2017 Oct; 153(4):1082-1095. PubMed ID: 28625833
[TBL] [Abstract][Full Text] [Related]
17. Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer.
Udyavar AR; Hoeksema MD; Clark JE; Zou Y; Tang Z; Li Z; Li M; Chen H; Statnikov A; Shyr Y; Liebler DC; Field J; Eisenberg R; Estrada L; Massion PP; Quaranta V
BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S1. PubMed ID: 24564859
[TBL] [Abstract][Full Text] [Related]
18. Proteogenomic analysis of human chromosome 9-encoded genes from human samples and lung cancer tissues.
Ahn JM; Kim MS; Kim YI; Jeong SK; Lee HJ; Lee SH; Paik YK; Pandey A; Cho JY
J Proteome Res; 2014 Jan; 13(1):137-46. PubMed ID: 24274035
[TBL] [Abstract][Full Text] [Related]
19. Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathways.
Zhang Y; Chen F; Chandrashekar DS; Varambally S; Creighton CJ
Nat Commun; 2022 May; 13(1):2669. PubMed ID: 35562349
[TBL] [Abstract][Full Text] [Related]
20. Identification of genes (SPON2 and C20orf2) differentially expressed between cancerous and noncancerous lung cells by mRNA differential display.
Manda R; Kohno T; Matsuno Y; Takenoshita S; Kuwano H; Yokota J
Genomics; 1999 Oct; 61(1):5-14. PubMed ID: 10512675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
